Metronidazole Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy
Condition:   Helicobacter Pylori Eradication Interventions:   Drug: Vonoprazan and Amoxicillin;   Drug: Vonoprazan, Amoxicillin and Clarithromycin;   Drug: Rabeprazole, Amoxicillin, Clarithromycin and Metronidazole Sponsor:   Kaohsiung Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2022 Category: Research Source Type: clinical trials

Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment - a Randomized Trial
Condition:   Helicobacter Pylori Infection Interventions:   Drug: Pariet;   Drug: Amolin;   Drug: Klaricid;   Drug: Flagyl Sponsor:   Chang Gung Memorial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2021 Category: Research Source Type: clinical trials